Nitinol-based Interventional Device - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB506249546

Publication Date:

June 10, 2024

Pages:

138

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Nitinol is a special metal that have the ability to restore their original shape after severe deformation. The nitinol medical devices include nitinol stents, nitinol guidewires, nitinol filters etc
The global market for Nitinol-based Interventional Device was estimated to be worth US$ 21890 million in 2023 and is forecast to a readjusted size of US$ 36460 million by 2030 with a CAGR of 7.5% during the forecast period 2024-2030
The Nitinol-based Interventional Device market is driven by the growing demand for minimally invasive medical procedures and the unique properties of Nitinol alloy in interventional device design. Nitinol, a shape memory alloy, offers remarkable flexibility, shape retention, and biocompatibility, making it an ideal material for various interventional devices like stents, guidewires, and filters. The rise in chronic diseases, such as cardiovascular conditions and peripheral artery diseases, contributes to market growth as healthcare professionals seek advanced devices that ensure precise placement and effective treatment. Moreover, Nitinol's ability to change shape with temperature variations aligns with improved device deployment and reduced patient discomfort. However, the market also faces challenges, including manufacturing complexities due to the unique properties of Nitinol and the need for rigorous testing to ensure device reliability. Additionally, addressing concerns related to long-term device performance and biocompatibility, and managing potential allergic reactions, can pose obstacles for manufacturers. To succeed, companies must focus on material advancements, precise device engineering, and addressing the challenges to provide safe and efficient Nitinol-based interventional devices that enhance patient outcomes and revolutionize minimally invasive medical procedures.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Nitinol-based Interventional Device, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Nitinol-based Interventional Device by region & country, by Type, and by Application.
The Nitinol-based Interventional Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nitinol-based Interventional Device.
Market Segmentation
By Company
Abbott
Edwards Lifesciences
Medtronic
Boston Scientific
TERUMO
BD
Stryker
Cook Medical
Cordis
B. Braun
Biotronik
MicroPort
JOTEC
Acandis
ELLA-CS
Segment by Type:
Stents
Guidewires
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Nitinol-based Interventional Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Nitinol-based Interventional Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Nitinol-based Interventional Device in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Nitinol-based Interventional Device Product Introduction
1.2 Global Nitinol-based Interventional Device Market Size Forecast
1.2.1 Global Nitinol-based Interventional Device Sales Value (2019-2030)
1.2.2 Global Nitinol-based Interventional Device Sales Volume (2019-2030)
1.2.3 Global Nitinol-based Interventional Device Sales Price (2019-2030)
1.3 Nitinol-based Interventional Device Market Trends & Drivers
1.3.1 Nitinol-based Interventional Device Industry Trends
1.3.2 Nitinol-based Interventional Device Market Drivers & Opportunity
1.3.3 Nitinol-based Interventional Device Market Challenges
1.3.4 Nitinol-based Interventional Device Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Nitinol-based Interventional Device Players Revenue Ranking (2023)
2.2 Global Nitinol-based Interventional Device Revenue by Company (2019-2024)
2.3 Global Nitinol-based Interventional Device Players Sales Volume Ranking (2023)
2.4 Global Nitinol-based Interventional Device Sales Volume by Company Players (2019-2024)
2.5 Global Nitinol-based Interventional Device Average Price by Company (2019-2024)
2.6 Key Manufacturers Nitinol-based Interventional Device Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Nitinol-based Interventional Device Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Nitinol-based Interventional Device
2.9 Nitinol-based Interventional Device Market Competitive Analysis
2.9.1 Nitinol-based Interventional Device Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Nitinol-based Interventional Device Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nitinol-based Interventional Device as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Stents
3.1.2 Guidewires
3.1.3 Others
3.2 Global Nitinol-based Interventional Device Sales Value by Type
3.2.1 Global Nitinol-based Interventional Device Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Nitinol-based Interventional Device Sales Value, by Type (2019-2030)
3.2.3 Global Nitinol-based Interventional Device Sales Value, by Type (%) (2019-2030)
3.3 Global Nitinol-based Interventional Device Sales Volume by Type
3.3.1 Global Nitinol-based Interventional Device Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Nitinol-based Interventional Device Sales Volume, by Type (2019-2030)
3.3.3 Global Nitinol-based Interventional Device Sales Volume, by Type (%) (2019-2030)
3.4 Global Nitinol-based Interventional Device Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Nitinol-based Interventional Device Sales Value by Application
4.2.1 Global Nitinol-based Interventional Device Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Nitinol-based Interventional Device Sales Value, by Application (2019-2030)
4.2.3 Global Nitinol-based Interventional Device Sales Value, by Application (%) (2019-2030)
4.3 Global Nitinol-based Interventional Device Sales Volume by Application
4.3.1 Global Nitinol-based Interventional Device Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Nitinol-based Interventional Device Sales Volume, by Application (2019-2030)
4.3.3 Global Nitinol-based Interventional Device Sales Volume, by Application (%) (2019-2030)
4.4 Global Nitinol-based Interventional Device Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Nitinol-based Interventional Device Sales Value by Region
5.1.1 Global Nitinol-based Interventional Device Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Nitinol-based Interventional Device Sales Value by Region (2019-2024)
5.1.3 Global Nitinol-based Interventional Device Sales Value by Region (2025-2030)
5.1.4 Global Nitinol-based Interventional Device Sales Value by Region (%), (2019-2030)
5.2 Global Nitinol-based Interventional Device Sales Volume by Region
5.2.1 Global Nitinol-based Interventional Device Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Nitinol-based Interventional Device Sales Volume by Region (2019-2024)
5.2.3 Global Nitinol-based Interventional Device Sales Volume by Region (2025-2030)
5.2.4 Global Nitinol-based Interventional Device Sales Volume by Region (%), (2019-2030)
5.3 Global Nitinol-based Interventional Device Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Nitinol-based Interventional Device Sales Value, 2019-2030
5.4.2 North America Nitinol-based Interventional Device Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Nitinol-based Interventional Device Sales Value, 2019-2030
5.5.2 Europe Nitinol-based Interventional Device Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Nitinol-based Interventional Device Sales Value, 2019-2030
5.6.2 Asia Pacific Nitinol-based Interventional Device Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Nitinol-based Interventional Device Sales Value, 2019-2030
5.7.2 South America Nitinol-based Interventional Device Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Nitinol-based Interventional Device Sales Value, 2019-2030
5.8.2 Middle East & Africa Nitinol-based Interventional Device Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Nitinol-based Interventional Device Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Nitinol-based Interventional Device Sales Value
6.2.1 Key Countries/Regions Nitinol-based Interventional Device Sales Value, 2019-2030
6.2.2 Key Countries/Regions Nitinol-based Interventional Device Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Nitinol-based Interventional Device Sales Value, 2019-2030
6.3.2 United States Nitinol-based Interventional Device Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Nitinol-based Interventional Device Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Nitinol-based Interventional Device Sales Value, 2019-2030
6.4.2 Europe Nitinol-based Interventional Device Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Nitinol-based Interventional Device Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Nitinol-based Interventional Device Sales Value, 2019-2030
6.5.2 China Nitinol-based Interventional Device Sales Value by Type (%), 2023 VS 2030
6.5.3 China Nitinol-based Interventional Device Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Nitinol-based Interventional Device Sales Value, 2019-2030
6.6.2 Japan Nitinol-based Interventional Device Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Nitinol-based Interventional Device Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Nitinol-based Interventional Device Sales Value, 2019-2030
6.7.2 South Korea Nitinol-based Interventional Device Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Nitinol-based Interventional Device Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Nitinol-based Interventional Device Sales Value, 2019-2030
6.8.2 Southeast Asia Nitinol-based Interventional Device Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Nitinol-based Interventional Device Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Nitinol-based Interventional Device Sales Value, 2019-2030
6.9.2 India Nitinol-based Interventional Device Sales Value by Type (%), 2023 VS 2030
6.9.3 India Nitinol-based Interventional Device Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbott
7.1.1 Abbott Company Information
7.1.2 Abbott Introduction and Business Overview
7.1.3 Abbott Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Abbott Nitinol-based Interventional Device Product Offerings
7.1.5 Abbott Recent Development
7.2 Edwards Lifesciences
7.2.1 Edwards Lifesciences Company Information
7.2.2 Edwards Lifesciences Introduction and Business Overview
7.2.3 Edwards Lifesciences Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Edwards Lifesciences Nitinol-based Interventional Device Product Offerings
7.2.5 Edwards Lifesciences Recent Development
7.3 Medtronic
7.3.1 Medtronic Company Information
7.3.2 Medtronic Introduction and Business Overview
7.3.3 Medtronic Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Medtronic Nitinol-based Interventional Device Product Offerings
7.3.5 Medtronic Recent Development
7.4 Boston Scientific
7.4.1 Boston Scientific Company Information
7.4.2 Boston Scientific Introduction and Business Overview
7.4.3 Boston Scientific Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Boston Scientific Nitinol-based Interventional Device Product Offerings
7.4.5 Boston Scientific Recent Development
7.5 TERUMO
7.5.1 TERUMO Company Information
7.5.2 TERUMO Introduction and Business Overview
7.5.3 TERUMO Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2019-2024)
7.5.4 TERUMO Nitinol-based Interventional Device Product Offerings
7.5.5 TERUMO Recent Development
7.6 BD
7.6.1 BD Company Information
7.6.2 BD Introduction and Business Overview
7.6.3 BD Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2019-2024)
7.6.4 BD Nitinol-based Interventional Device Product Offerings
7.6.5 BD Recent Development
7.7 Stryker
7.7.1 Stryker Company Information
7.7.2 Stryker Introduction and Business Overview
7.7.3 Stryker Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Stryker Nitinol-based Interventional Device Product Offerings
7.7.5 Stryker Recent Development
7.8 Cook Medical
7.8.1 Cook Medical Company Information
7.8.2 Cook Medical Introduction and Business Overview
7.8.3 Cook Medical Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Cook Medical Nitinol-based Interventional Device Product Offerings
7.8.5 Cook Medical Recent Development
7.9 Cordis
7.9.1 Cordis Company Information
7.9.2 Cordis Introduction and Business Overview
7.9.3 Cordis Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Cordis Nitinol-based Interventional Device Product Offerings
7.9.5 Cordis Recent Development
7.10 B. Braun
7.10.1 B. Braun Company Information
7.10.2 B. Braun Introduction and Business Overview
7.10.3 B. Braun Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2019-2024)
7.10.4 B. Braun Nitinol-based Interventional Device Product Offerings
7.10.5 B. Braun Recent Development
7.11 Biotronik
7.11.1 Biotronik Company Information
7.11.2 Biotronik Introduction and Business Overview
7.11.3 Biotronik Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Biotronik Nitinol-based Interventional Device Product Offerings
7.11.5 Biotronik Recent Development
7.12 MicroPort
7.12.1 MicroPort Company Information
7.12.2 MicroPort Introduction and Business Overview
7.12.3 MicroPort Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2019-2024)
7.12.4 MicroPort Nitinol-based Interventional Device Product Offerings
7.12.5 MicroPort Recent Development
7.13 JOTEC
7.13.1 JOTEC Company Information
7.13.2 JOTEC Introduction and Business Overview
7.13.3 JOTEC Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2019-2024)
7.13.4 JOTEC Nitinol-based Interventional Device Product Offerings
7.13.5 JOTEC Recent Development
7.14 Acandis
7.14.1 Acandis Company Information
7.14.2 Acandis Introduction and Business Overview
7.14.3 Acandis Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Acandis Nitinol-based Interventional Device Product Offerings
7.14.5 Acandis Recent Development
7.15 ELLA-CS
7.15.1 ELLA-CS Company Information
7.15.2 ELLA-CS Introduction and Business Overview
7.15.3 ELLA-CS Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2019-2024)
7.15.4 ELLA-CS Nitinol-based Interventional Device Product Offerings
7.15.5 ELLA-CS Recent Development
8 Industry Chain Analysis
8.1 Nitinol-based Interventional Device Industrial Chain
8.2 Nitinol-based Interventional Device Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Nitinol-based Interventional Device Sales Model
8.5.2 Sales Channel
8.5.3 Nitinol-based Interventional Device Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Abbott
Edwards Lifesciences
Medtronic
Boston Scientific
TERUMO
BD
Stryker
Cook Medical
Cordis
B. Braun
Biotronik
MicroPort
JOTEC
Acandis
ELLA-CS

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂